OmniAb, Inc. (OABI)
NASDAQ·Healthcare·Biotechnology
$2.29
-2.35%
Mkt Cap $297.73M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$4.00
Range $4.00 – $4.00
Implied Upside
+75.1%
Consensus $4.00 vs current $2.29
NASDAQ·Healthcare·Biotechnology
$2.29
-2.35%
Mkt Cap $297.73M
No recent rating data.
Price Target (1 analysts)
$4.00
Range $4.00 – $4.00
+75.1%
Consensus $4.00 vs current $2.29